Late of Sunday, Emergent BioSolutions Inc said, a key U.S. agency has increased an order related to the manufacturing of Johnson & Johnson’s COVID-19 vaccine, by $23 million. “The amount will be used to purchase biologics equipment specific to J&J’s… Read More ›